☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Cayman Islands
|
001-40175
|
98-1572401
|
||
(State or other jurisdiction of
incorporation or organization)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
1 Circle Star Way
San Carlos, California
|
94070
|
|
(Address Of Principal Executive Offices)
|
(Zip Code)
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
||
Class A ordinary shares, par value $0.0001 per share
|
SVFC
|
Nasdaq
|
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated
filer
|
☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Page
|
||||||
Item 1.
|
1 | |||||
1 | ||||||
2 | ||||||
3 | ||||||
4 | ||||||
5 | ||||||
Item 2.
|
17 | |||||
Item 3.
|
21 | |||||
Item 4.
|
21 | |||||
Item 1.
|
22 | |||||
Item 1A.
|
22 | |||||
Item 2.
|
23 | |||||
Item 3.
|
23 | |||||
Item 4.
|
23 | |||||
Item 5.
|
23 | |||||
Item 6.
|
23 |
|
|
September 30, 2021
|
|
|
December 31, 2020
|
|
||
|
|
(Unaudited)
|
|
|
|
|
||
Assets
|
|
|
||||||
Current assets:
|
|
|
||||||
Cash
|
$
|
2,707,252 |
$
|
— | ||||
Prepaid expenses
|
1,083,200 | 6,154 | ||||||
|
|
|
|
|||||
Total current assets
|
3,790,452 | 6,154 | ||||||
Investments held in Trust Account
|
320,010,848 | — | ||||||
Deferred offering costs associated with the initial public offering
|
— | 126,750 | ||||||
|
|
|
|
|||||
Total Assets
|
$
|
323,801,300
|
|
$
|
132,904
|
|
||
|
|
|
|
|||||
Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit)
|
||||||||
Current liabilities:
|
||||||||
Accounts payable
|
$ | 1,768,257 | $ | 9,000 | ||||
Accrued expenses
|
2,205,570 | 100,000 | ||||||
Due to related party
|
675,123 | — | ||||||
Note payable - related party
|
— | 17,750 | ||||||
|
|
|
|
|||||
Total current liabilities
|
4,648,950 | 126,750 | ||||||
Deferred underwriting commissions
|
11,200,000 | — | ||||||
|
|
|
|
|||||
Total liabilities
|
15,848,950 | 126,750 | ||||||
Commitments and Contingencies
|
||||||||
Class A ordinary shares subject to possible redemption, $0.0001 par value; 32,000,000 and -0- shares issued and outstanding, at $10.00 per share as of September 30, 2021 and December 31, 2020, respectively
|
320,000,000 | — | ||||||
Shareholders’ Equity (Deficit)
|
||||||||
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
|
— | — | ||||||
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 1,040,000 and -0- shares issued and outstanding as of September 30, 202
1
(excluding 32,000,000 shares subject to possible redemption)
and December 31, 2020, respectively
|
104 | — | ||||||
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,000,000
shares issued and outstanding as of September 30, 2021 and December 31, 2020
|
800 | 800 | ||||||
Additional paid-in capital
|
— | 24,200 | ||||||
Accumulated deficit
|
(12,048,554 | ) | (18,846 | ) | ||||
|
|
|
|
|||||
Total shareholders’ equity (deficit)
|
(12,047,650 | ) | 6,154 | |||||
|
|
|
|
|||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit)
|
$
|
323,801,300
|
|
$
|
132,904
|
|
||
|
|
|
|
|
|
For the Three
Months Ended September 30, 2021 |
|
|
For the Nine
Months Ended September 30, 2021 |
|
||
General and administrative expenses
|
$
|
1,921,010
|
$
|
4,923,011 | ||||
General and administrative expenses - related party
|
30,000 | 70,000 | ||||||
|
|
|
|
|||||
Loss from operations
|
(1,951,010 | ) | (4,993,011 | ) | ||||
Other income
|
||||||||
Income from investments held in Trust Account
|
4,916 | 10,848 | ||||||
|
|
|
|
|||||
Net loss
|
$ | (1,946,094 | ) | $ | (4,982,163 | ) | ||
|
|
|
|
|||||
Basic and diluted weighted average shares outstanding of Class A ordinary shares subject to possible redemption
|
32,000,000 | 23,912,088 | ||||||
|
|
|
|
|||||
Basic and diluted net loss per ordinary share, Class A ordinary shares subject to possible redemption
|
$ | (0.05 | ) | $ | (0.15 | ) | ||
|
|
|
|
|||||
Basic and diluted weighted average shares outstanding of non-redeemable ordinary shares
|
9,040,000 | 8,524,396 | ||||||
|
|
|
|
|||||
Basic and diluted net loss per ordinary share, non-redeemable ordinary shares
|
$ | (0.05 | ) | $ | (0.15 | ) | ||
|
|
|
|
|
|
Ordinary Shares
|
|
|
Additional
|
|
|
|
|
|
Total
|
|
||||||||||||||||
|
|
Class A
|
|
|
Class B
|
|
|
Paid-in
|
|
|
Accumulated
|
|
|
Shareholders’
|
|
|||||||||||||
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Deficit
|
|
|
Equity (Deficit)
|
|
|||||||
Balance - December 31, 2020
|
|
—
|
|
$
|
—
|
|
|
8,000,000
|
|
$
|
800
|
|
$
|
24,200
|
|
$
|
(18,846
|
)
|
$
|
6,154
|
|
|||||||
Sale of private placement shares to Sponsor in private placement, net of offering costs
|
1,040,000 | 104 | — | — | 10,383,779 | — | 10,383,883 | |||||||||||||||||||||
Accretion of Class A ordinary shares subject to redemption
|
— | — | — | — | (10,407,979 | ) |
(7,047,545
|
)
|
(17,455,524 | ) | ||||||||||||||||||
Net loss
|
— | — | — | — | — | (523,923 | ) | (523,923 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - March 31, 2021 (unaudited)
|
|
1,040,000
|
|
|
104
|
|
|
8,000,000
|
|
|
800
|
|
|
—
|
|
|
(7,590,314
|
) |
|
(7,589,410
|
)
|
|||||||
Net loss
|
— | — | — | — | — | (2,512,146 | ) | (2,512,146 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - June 30, 2021 (unaudited)
|
|
1,040,000
|
|
$
|
104
|
|
|
8,000,000
|
|
$
|
800
|
|
$
|
—
|
|
$
|
(10,102,460
|
)
|
$
|
(10,101,556
|
)
|
|||||||
Net loss
|
— | — | — | — | — | (1,946,094 | ) | (1,946,094 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - September 30, 2021 (unaudited)
|
|
1,040,000
|
|
$
|
104
|
|
|
8,000,000
|
|
$
|
800
|
|
$
|
—
|
|
$
|
(12,048,554
|
)
|
$
|
(12,047,650
|
)
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Operating Activities:
|
||||
Net loss
|
$ | (4,982,163 | ) | |
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||
Income from investments held in Trust Account
|
(10,848 | ) | ||
General and administrative expenses paid by related party under note payable
|
44,617 | |||
Changes in operating assets and liabilities:
|
||||
Prepaid expenses
|
(1,057,446 | ) | ||
Accounts payable
|
1,761,778 | |||
Accrued expenses
|
2,132,003 | |||
Due to related party
|
623,623 | |||
|
|
|||
Net cash used in operating activities
|
(1,488,436 | ) | ||
|
|
|||
Cash Flows from Investing Activities:
|
||||
Cash deposited in Trust Account
|
(320,000,000 | ) | ||
|
|
|||
Net cash used in investing activities
|
(320,000,000 | ) | ||
|
|
|||
Cash Flows from Financing Activities:
|
||||
Repayment of note payable to related party
|
(413,562 | ) | ||
Proceeds received from initial public offering, gross
|
320,000,000 | |||
Proceeds received from private placement
|
10,400,000 | |||
Offering costs paid
|
(5,790,750 | ) | ||
|
|
|||
Net cash provided by financing activities
|
324,195,688 | |||
|
|
|||
Net increase in cash
|
2,707,252 | |||
Cash - beginning of the period
|
— | |||
|
|
|||
Cash - end of the period
|
$
|
2,707,252
|
|
|
|
|
|||
Supplemental disclosure of noncash investing and financing activities:
|
||||
Offering costs included in accounts payable
|
$ | 6,479 | ||
Offering costs included in accrued expenses
|
$ | 73,567 | ||
Offering costs paid by related party under note payable
|
$ | 322,595 | ||
Offering costs included in due to related party
|
$ | 51,500 | ||
Reversal of offering costs included in accrued expenses in prior year
|
$ | 100,000 | ||
Prepaid expenses paid by related party through note payable
|
$ | 19,600 | ||
Outstanding accounts payable balance paid by related party under note payable
|
$ | 9,000 | ||
Deferred underwriting commissions
|
$ | 11,200,000 |
• |
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
|
• |
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
|
• |
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
|
|
|
For the Three Months Ended
September 30, 2021 |
|
|
For the Nine Months Ended
September 30, 2021 |
|
||||||||||
|
|
Class A
ordinary shares subject to possible
redemption
|
|
|
Non-redeemable
ordinary shares
|
|
|
Class A
ordinary shares subject to possible
redemption
|
|
|
Non-redeemable
ordinary shares
|
|
||||
Basic and diluted net loss per ordinary share:
|
||||||||||||||||
Numerator:
|
||||||||||||||||
Allocation of net loss
|
$ | (1,517,422 | ) | $ | (428,672 | ) | $ | (3,672,837 | ) | $ | (1,309,326 | ) | ||||
Denominator:
|
||||||||||||||||
Basic and diluted weighted average ordinary share outstanding
|
32,000,000 | 9,040,000 | 23,912,088 | 8,524,396 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net loss per ordinary share
|
$ | (0.05 | ) | $ | (0.05 | ) | $ | (0.15 | ) | $ | (0.15 | ) | ||||
|
|
|
|
|
|
|
|
|
|
As of September 30, 2021
|
|
|
Gross proceeds
|
|
$
|
320,000,000
|
|
Less:
|
|
|||
Class A ordinary shares issuance costs
|
|
|
(17,455,524
|
)
|
Plus:
|
|
|||
Accretion of carrying value to redemption value
|
|
|
17,455,524
|
|
|
|
|
|
|
Class A ordinary shares
subject
to possible redemption
|
|
$
|
320,000,000
|
|
|
|
|
|
Description
|
|
Quoted
Prices
in Active
Markets
(Level 1)
|
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
|
Significant
Other
Unobservable
Inputs
(Level 3)
|
|
|||
Investments held in Trust Account
|
$ | 320,010,848 | — | — |
|
|
EPS for Class A ordinary shares subject to possible
redemption
|
|
|||||||||
|
As Previously
Reported |
|
|
Adjustment
|
|
|
As Restated
|
|
||||
Form 10-Q (September 30, 2021) - three months ended September 30, 2021
|
|
|
|
|||||||||
Weighted average shares outstanding
|
|
|
33,040,000
|
|
|
|
(1,040,000
|
)
|
|
|
32,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted earnings per ordinary share
|
|
$
|
(0.05
|
)
|
|
$
|
0.00
|
|
|
$
|
(0.05
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Form 10-Q (September 30, 2021) - nine months ended September 30, 2021
|
|
|
|
|||||||||
Weighted average shares outstanding
|
|
|
24,689,231
|
|
|
|
(777,143
|
)
|
|
|
23,912,088
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted earnings per ordinary share
|
|
$
|
(0.15
|
)
|
|
$
|
(0.00
|
)
|
|
$
|
(0.15
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EPS for non-redeemable ordinary shares
|
|
|||||||||
|
As Previously
Reported |
|
|
Adjustment
|
|
|
As Restated
|
|
||||
Form 10-Q (September 30, 2021) - three months ended September 30, 2021
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding
|
|
|
8,000,000
|
|
|
|
1,040,000
|
|
|
|
9,040,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted earnings per ordinary share
|
|
$
|
(0.05
|
)
|
|
$
|
0.00
|
|
|
$
|
(0.05
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Form 10-Q (September 30, 2021) - nine months ended September 30, 2021
|
|
|
|
|||||||||
Weighted average shares outstanding
|
|
|
7,747,253
|
|
|
|
777,143
|
|
|
|
8,524,396
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted earnings per ordinary share
|
|
$
|
(0.15
|
)
|
|
$
|
(0.00
|
)
|
|
$
|
(0.15
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations. (Restated)
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
Item 4.
|
Controls and Procedures (Restated)
|
Item 1.
|
Legal Proceedings
|
Item 1A.
|
Risk Factors
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds.
|
Item 3.
|
Defaults upon Senior Securities
|
Item 4.
|
Mine Safety Disclosures.
|
Item 5.
|
Other Information.
|
Item 6.
|
Exhibits.
|
*
|
These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
|
Dated: January 25, 2022 |
SVF INVESTMENT CORP. 3
|
|||||
By: |
/s/ Ioannis Pipilis
|
|||||
Name: | Ioannis Pipilis | |||||
Title: | Chief Executive Officer |
Exhibit 10.1
AMENDMENT LETTER
SVF Investment Corp. 3
Walkers Corporate Limited
190 Elgin Avenue
George Town
Grand Cayman KY1-9008
Cayman Islands
SVF Sponsor III (DE) LLC
c/o Corporation Service Company
251 Little Falls Drive
Wilmington DE 19809, U.S.
Ladies and Gentlemen:
This letter amends the loan agreement dated 10 August 2021 between SVF Investment Corp. 3 (the Borrower) and SVF Sponsor III (DE) LLC (the Lender), entered into in connection with the loan facility made available to the Borrower by the Lender (the Loan Agreement). Terms used in this letter and not defined have the meanings given to such terms in the Loan Agreement.
Pursuant to Clause 15 (Amendments and Waivers) and the definition of Commitment in Clause 1.1 (Definitions) of the Loan Agreement, the Borrower and the Lender may agree a higher amount of Commitment to be made available for the loan facility. The Borrower and the Lender hereby consent to and agree that the Commitment be increased from U.S.$2,000,000 to U.S.$3,000,000 with effect from the date of this letter.
This letter may be executed in one or more counterparts, each of which shall be deemed to be an original but all of which taken together shall constitute one and the same instrument.
The provisions of Clause 18 (Governing Law) and Clause 19 (Enforcement) of the Loan Agreement shall apply to this letter as if set out here in full.
The Borrower
By: | ) | /s/ Ioannis Pipilis | ||
) | ||||
For and on behalf of | ) |
|
||
SVF Investment Corp. 3 | ) | Name: Ioannis Pipilis | ||
Title: Chief Executive Officer |
The Lender
By: | ) | |||
) | /s/ Kokoro Motegi | |||
For and on behalf of | ) |
|
||
SVF Sponsor III (DE) LLC | ) | Name: Kokoro Motegi | ||
Title: Manager |
Exhibit 10.2
INDEMNITY AGREEMENT
This Indemnity Agreement (this Agreement) is made effective as of 10 August 2021, by and between SVF Investment Corp. 3, a Cayman Islands exempted company (the Company), and SVF Sponsor III (DE) LLC (the Sponsor).
WHEREAS, the Companys registration statement on Form S-1, File No. 333-252788for the Companys initial public offering (the Offering) disclosed that the Company and the Sponsor have agreed to enter into an agreement whereby the Company indemnifies the Sponsor and its affiliates, including, without limitation, SoftBank Investment Advisers, SB Investment Advisers (UK) Limited, SB Investment Advisers (US) Inc., and SoftBank Group Corp. (collectively the SB Entities) from any claims made by the Company or a third party in respect of any investment opportunities sourced by them, any liability arising with respect to their activities in connection with the Companys affairs, and for any services that are provided between the Company and any such party.
The Company covenants and agrees (i) that the SB Entities and their respective current, former or future employees, directors, officers, partners, managers, agents, successors and assigns (collectively, the SB Entity Indemnitees) shall not be liable to the Company or any of its subsidiaries or affiliates for any loss, liability, damage or expense arising from or in connection with any services, or from any SB Entity Indemnitees financial interest (whether through equity, debt or otherwise) in or control or alleged control of the Company, including any investment opportunities sourced by them, and any liability arising with respect to their activities in connection with the Companys affairs (any of the foregoing, collectively, the SB Capacity), except to the extent a court of competent jurisdiction has determined by entry of a final and non-appealable judgment to have resulted by fraud or willful misconduct by a SB Entity Indemnitee and (ii) to, at its own cost and expense, defend, indemnify and hold harmless the SB Entity Indemnitees from and against any and all claims against a SB Entity Indemnitee by the Company, its subsidiaries or any other person with respect to, or in any way related to, any SB Capacity and any and all losses, liabilities, damages or expenses (including reasonable attorneys fees) arising or resulting therefrom, except to the extent a court of competent jurisdiction has determined by entry of a final and non-appealable judgment to have resulted by fraud or willful misconduct by a SB Entity Indemnitee; provided, that in no event shall any SB Entity Indemnitee have any right or claim of any kind pursuant to this Agreement in or to the trust account established to hold the proceeds of the Offering. Each SB Entity Indemnitee is an express and intended third party beneficiary of this Agreement.
This Agreement constitutes the entire agreement and understanding of the parties hereto in respect of its subject matter and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby.
This Agreement may not be amended, modified or waived as to any particular provision, except by a written instrument executed by the parties hereto.
The parties may not assign this Agreement and any of their rights, interests, or obligations hereunder without the consent of the other party.
This Agreement shall be governed by, construed in accordance with, and interpreted pursuant to the laws of the State of New York, without giving effect to its choice of laws principles that will apply the laws of another jurisdiction.
This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same agreement. Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement.
IN WITNESS WHEREOF, the parties have duly executed this Agreement as of the date first written above.
SVF Investment Corp. 3 |
||
By: | /s/ Navneet Govil | |
Name: | Navneet Govil | |
Title: | Director |
SVF Sponsor III (DE) LLC | ||
By: | /s/ Daniel Elefant | |
Name: |
Daniel Elefant |
|
Title: | Director |
EXHIBIT 31.1
CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a)
UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Ioannis Pipilis, certify that:
1. |
I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 of SVF Investment Corp. 3.; |
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. |
The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: |
a. |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. |
[Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313]; |
c. |
Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d. |
Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
5. |
The registrants other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
a. |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and |
b. |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls over financial reporting. |
Date: January 25, 2022 | By: |
/s/ Ioannis Pipilis |
||||
Ioannis Pipilis | ||||||
Chief Executive Officer and Chairman of the Board of Directors | ||||||
(Principal Executive Officer) |
EXHIBIT 31.2
CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a)
UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Navneet Govil, certify that:
1. |
I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 of SVF Investment Corp. 3; |
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. |
The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: |
a. |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. |
[Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313]; |
c. |
Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d. |
Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
5. |
The registrants other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
a. |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and |
b. |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls over financial reporting. |
Date: January 25, 2022 | By: |
/s/ Navneet Govil |
||||
Navneet Govil | ||||||
Chief Financial Officer and Director | ||||||
(Principal Financial and Accounting Officer) |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of SVF Investment Corp. 3 (the Company) on Form 10-Q for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Ioannis Pipilis, Chief Executive Officer and Chairman of the Board of Directors, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) |
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) |
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: January 25, 2022
/s/ Ioannis Pipilis |
||
Name: | Ioannis Pipilis | |
Title: | Chief Executive Officer and Chairman of the Board of Directors | |
(Principal Executive Officer) |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of SVF Investment Corp. 3 (the Company) on Form 10-Q for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Navneet Govil, Chief Financial Officer and Director, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) |
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) |
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: January 25, 2022
/s/ Navneet Govil |
||
Name: | Navneet Govil | |
Title: | Chief Financial Officer and Director | |
(Principal Financial and Accounting Officer) |